Envista (NYSE:NVST) Lowered to “Hold” Rating by Zacks Research

Envista (NYSE:NVST) was downgraded by stock analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a report released on Monday,Zacks.com reports.

Several other equities research analysts have also recently weighed in on the company. Piper Sandler reissued a “neutral” rating and issued a $25.00 price target (up from $21.00) on shares of Envista in a research note on Friday, February 6th. William Blair raised Envista from a “hold” rating to an “outperform” rating in a research note on Friday, February 6th. UBS Group increased their price target on Envista from $22.00 to $25.00 and gave the company a “neutral” rating in a research note on Tuesday, February 3rd. Mizuho increased their price target on Envista from $24.00 to $27.00 and gave the company a “neutral” rating in a research note on Tuesday, February 10th. Finally, Wall Street Zen raised Envista from a “buy” rating to a “strong-buy” rating in a research note on Monday, January 26th. Seven investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $27.75.

Envista Price Performance

Envista stock opened at $25.25 on Monday. The company has a market capitalization of $4.14 billion, a PE ratio of 90.16, a P/E/G ratio of 1.76 and a beta of 0.98. The stock has a 50-day moving average price of $26.72 and a two-hundred day moving average price of $23.14. The company has a current ratio of 2.38, a quick ratio of 2.04 and a debt-to-equity ratio of 0.47. Envista has a 12 month low of $14.22 and a 12 month high of $30.42.

Envista (NYSE:NVST) last issued its quarterly earnings results on Thursday, February 5th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.32 by $0.06. Envista had a return on equity of 6.54% and a net margin of 1.73%.The company’s revenue was up 15.0% on a year-over-year basis. During the same period in the previous year, the business earned $0.24 earnings per share. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Analysts expect that Envista will post 1 EPS for the current year.

Insider Buying and Selling

In other Envista news, SVP Mischa Reis sold 9,675 shares of the firm’s stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $30.00, for a total value of $290,250.00. Following the completion of the sale, the senior vice president owned 32,382 shares of the company’s stock, valued at approximately $971,460. This trade represents a 23.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.66% of the company’s stock.

Institutional Investors Weigh In On Envista

Hedge funds have recently added to or reduced their stakes in the company. Farther Finance Advisors LLC grew its stake in Envista by 317.6% in the third quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock valued at $27,000 after acquiring an additional 1,026 shares during the period. Caitong International Asset Management Co. Ltd grew its stake in Envista by 16,711.1% in the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after acquiring an additional 1,504 shares during the period. Allworth Financial LP grew its stake in Envista by 75.4% in the fourth quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after acquiring an additional 776 shares during the period. UMB Bank n.a. grew its stake in Envista by 46.1% in the fourth quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock valued at $44,000 after acquiring an additional 636 shares during the period. Finally, IFP Advisors Inc grew its stake in Envista by 102.9% in the fourth quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock valued at $46,000 after acquiring an additional 1,071 shares during the period.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.